462 related articles for article (PubMed ID: 25794514)
1. Comparative effectiveness of screening strategies for Lynch syndrome.
Barzi A; Sadeghi S; Kattan MW; Meropol NJ
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25794514
[TBL] [Abstract][Full Text] [Related]
2. Universal Versus Targeted Screening for Lynch Syndrome: Comparing Ascertainment and Costs Based on Clinical Experience.
Erten MZ; Fernandez LP; Ng HK; McKinnon WC; Heald B; Koliba CJ; Greenblatt MS
Dig Dis Sci; 2016 Oct; 61(10):2887-2895. PubMed ID: 27384051
[TBL] [Abstract][Full Text] [Related]
3. Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis.
Ladabaum U; Wang G; Terdiman J; Blanco A; Kuppermann M; Boland CR; Ford J; Elkin E; Phillips KA
Ann Intern Med; 2011 Jul; 155(2):69-79. PubMed ID: 21768580
[TBL] [Abstract][Full Text] [Related]
4. Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing.
Ferguson SE; Aronson M; Pollett A; Eiriksson LR; Oza AM; Gallinger S; Lerner-Ellis J; Alvandi Z; Bernardini MQ; MacKay HJ; Mojtahedi G; Tone AA; Massey C; Clarke BA
Cancer; 2014 Dec; 120(24):3932-9. PubMed ID: 25081409
[TBL] [Abstract][Full Text] [Related]
5. Cost-Effectiveness Analysis of Different Genetic Testing Strategies for Lynch Syndrome in Taiwan.
Chen YE; Kao SS; Chung RH
PLoS One; 2016; 11(8):e0160599. PubMed ID: 27482709
[TBL] [Abstract][Full Text] [Related]
6. Screening for Lynch syndrome and referral to clinical genetics by selective mismatch repair protein immunohistochemistry testing: an audit and cost analysis.
Colling R; Church DN; Carmichael J; Murphy L; East J; Risby P; Kerr R; Chetty R; Wang LM
J Clin Pathol; 2015 Dec; 68(12):1036-9. PubMed ID: 26201544
[TBL] [Abstract][Full Text] [Related]
7. Family matters in lynch syndrome.
Kastrinos F; Steyerberg EW
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25794515
[No Abstract] [Full Text] [Related]
8. The predicted impact and cost-effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome.
Kang YJ; Killen J; Caruana M; Simms K; Taylor N; Frayling IM; Snowsill T; Huxley N; Coupe VM; Hughes S; Freeman V; Boussioutas A; Trainer AH; Ward RL; Mitchell G; Macrae FA; Canfell K
Med J Aust; 2020 Feb; 212(2):72-81. PubMed ID: 31595523
[TBL] [Abstract][Full Text] [Related]
9. Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation.
Snowsill T; Coelho H; Huxley N; Jones-Hughes T; Briscoe S; Frayling IM; Hyde C
Health Technol Assess; 2017 Sep; 21(51):1-238. PubMed ID: 28895526
[TBL] [Abstract][Full Text] [Related]
10. Population-based molecular screening for Lynch syndrome: implications for personalized medicine.
Ward RL; Hicks S; Hawkins NJ
J Clin Oncol; 2013 Jul; 31(20):2554-62. PubMed ID: 23733757
[TBL] [Abstract][Full Text] [Related]
11. Initiation of universal tumor screening for Lynch syndrome in colorectal cancer patients as a model for the implementation of genetic information into clinical oncology practice.
Cohen SA; Laurino M; Bowen DJ; Upton MP; Pritchard C; Hisama F; Jarvik G; Fichera A; Sjoding B; Bennett RL; Naylor L; Jacobson A; Burke W; Grady WM
Cancer; 2016 Feb; 122(3):393-401. PubMed ID: 26480326
[TBL] [Abstract][Full Text] [Related]
12. A model-based assessment of the cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients.
Snowsill T; Huxley N; Hoyle M; Jones-Hughes T; Coelho H; Cooper C; Frayling I; Hyde C
BMC Cancer; 2015 Apr; 15():313. PubMed ID: 25910169
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of reflex testing for Lynch syndrome in women with endometrial cancer in the UK setting.
Snowsill TM; Ryan NAJ; Crosbie EJ; Frayling IM; Evans DG; Hyde CJ
PLoS One; 2019; 14(8):e0221419. PubMed ID: 31469860
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of routine screening for Lynch syndrome in colorectal cancer patients up to 70 years of age.
Leenen CH; Goverde A; de Bekker-Grob EW; Wagner A; van Lier MG; Spaander MC; Bruno MJ; Tops CM; van den Ouweland AM; Dubbink HJ; Kuipers EJ; Dinjens WN; van Leerdam ME; Steyerberg EW
Genet Med; 2016 Oct; 18(10):966-73. PubMed ID: 26938782
[TBL] [Abstract][Full Text] [Related]
15. Universal Screening for Mismatch-Repair Deficiency in Endometrial Cancers to Identify Patients With Lynch Syndrome and Lynch-like Syndrome.
Watkins JC; Yang EJ; Muto MG; Feltmate CM; Berkowitz RS; Horowitz NS; Syngal S; Yurgelun MB; Chittenden A; Hornick JL; Crum CP; Sholl LM; Howitt BE
Int J Gynecol Pathol; 2017 Mar; 36(2):115-127. PubMed ID: 27556954
[TBL] [Abstract][Full Text] [Related]
16. Costs and outcomes of Lynch syndrome screening in the Australian colorectal cancer population.
Cenin DR; Naber SK; Lansdorp-Vogelaar I; Jenkins MA; Buchanan DD; Preen DB; Ee HC; O'Leary P
J Gastroenterol Hepatol; 2018 Oct; 33(10):1737-1744. PubMed ID: 29645364
[TBL] [Abstract][Full Text] [Related]
17. A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome.
Snowsill T; Huxley N; Hoyle M; Jones-Hughes T; Coelho H; Cooper C; Frayling I; Hyde C
Health Technol Assess; 2014 Sep; 18(58):1-406. PubMed ID: 25244061
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of genetic diagnostic strategies for Lynch syndrome in Italy.
Pastorino R; Basile M; Tognetto A; Di Marco M; Grossi A; Lucci-Cordisco E; Scaldaferri F; De Censi A; Federici A; Villari P; Genuardi M; Ricciardi W; Boccia S
PLoS One; 2020; 15(7):e0235038. PubMed ID: 32609729
[TBL] [Abstract][Full Text] [Related]
19. Influence of patient preferences on the cost-effectiveness of screening for Lynch syndrome.
Wang G; Kuppermann M; Kim B; Phillips KA; Ladabaum U
Am J Manag Care; 2012 May; 18(5):e179-85. PubMed ID: 22694112
[TBL] [Abstract][Full Text] [Related]
20. Impact of universal immunohistochemistry on Lynch syndrome diagnosis in an Australian colorectal cancer cohort.
Loh Z; Williams DS; Salmon L; Dow E; John T
Intern Med J; 2019 Oct; 49(10):1278-1284. PubMed ID: 30667141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
